Search JIM Advanced Search

Journal of Integrative Medicine ›› 2014, Vol. 12 ›› Issue (5): 401-408.doi: 10.1016/S2095-4964(14)60039-X

• Review •     Next Articles

Traditional Chinese medicine for treatment of liver diseases: Progress, challenges and opportunities

Chang-qing Zhaoa,b,c,d,e, Yang Zhoua,b,c,d,e, Jian Pingb,c,d,e, Lie-ming Xua,b,c,d,e   

  1. Department of Liver Cirrhosis, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
    Institute of Liver Diseases, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
    Key Laboratory of Liver and Kidney Diseases, Ministry of Education, Shanghai 201203, China
    Key Laboratory of Traditional Chinese Medicine Clinic, Shanghai 201203, China
    The Key Unit of Liver Diseases, State Administration of Traditional Chinese Medicine, Shanghai 201203, China
  • Received:2014-01-22 Accepted:2014-05-15 Online:2014-09-10 Published:2014-09-15

Traditional Chinese medicine (TCM) is commonly used in treating liver diseases worldwide, especially in China. The advantages of using TCM for treatment of liver diseases include: protecting hepatocytes, inhibiting hepatic inflammation and antifibrosis in the liver. In this article, we introduce TCM herbal preparations from the Chinese materia medica (such as Fuzheng Huayu) that are typically used for the treatment of liver diseases. Literature surrounding the mechanisms of TCM therapy for treatment of liver diseases is presented and discussed. We propose that side effects of herbal compounds are often under-appreciated, and that more care should be taken in the prescription of potentially hepatotoxic medicines. Further, to deepen the understanding of TCM mechanisms, new techniques and methodologies must be developed. Future studies will lead to the enhancement of clinical outcomes of TCM. As complementary and alternative therapies, TCMs will play an expanding role in the future of liver disease treatment.

Key words: Medicine, Chinese traditional, Drugs, Chinese herbal, Liver diseases (TCM), Liver cirrhosis, Hepatoprotective drugs, Hepatotoxicity, Reviews

[1] Liu BY, He LY, Liang ZW, Tong XY, Hu JQ, Jiao Q, Ni Q, Liu XM, Xie YM, Li P, Gao FZ, Wen TC, Liu WM . Effect of glucocorticoid with traditional Chinese medicine in severe acute aespiratory syndrome(SARS)[J]. Zhongguo Zhong Yao Za Zhi, 2005,30(23):1874-1877
[2] Wang E, Bussom S, Chen JG, Quinn C, Bedognetti D, Lam W, Guan F, Jiang ZL, Mark Y, Zhao YD, Stroncek DF, White J, Marincola FM, Cheng YC . Interaction of a traditional Chinese medicine(PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment[J]. BMC Med Genomics, 2011,4:38
doi: 10.1186/1755-8794-4-38
[3] Miller LH, Su XZ . Artemisinin: discovery from the Chinese herbal garden[J]. Cell, 2011,146(6):855-858
doi: 10.1016/j.cell.2011.08.024
Miller LH, Su XZ . Artemisinin: discovery from the Chinese herbal garden[J]. Cell, 2011,146(6):855-858
[4] Ashour ML, El-Readi MZ, Hamoud R, Eid SY, El Ahmady SH, Nibret E, Herrmann F, Youns M, Tahrani A, Kaufmann D, Wink M . Anti-infective and cytotoxic properties of Bupleurum marginatum[J]. Chin Med, 2014,9(1):4
doi: 10.1186/1749-8546-9-4
[5] Zhang W, Gao K, Liu J, Zhao H, Wang J, Li Y, Murtaza G, Chen J, Wang W . A review of the pharmacological mechanism of traditional Chinese medicine in the intervention of coronary heart disease and stroke[J]. Afr J Tradit Complement Altern Med, 2013,10(6):532-537
doi: 10.4314/ajtcam.v10i6.24
[6] Zhou YX, Zhang H, Peng C . Puerarin: a review of pharmacological effects[J]. Phytother Res, 2014,28(7):961-975
doi: 10.1002/ptr.v28.7
[7] Luo J, Xu H, Chen KJ . Potential benefits of Chinese herbal medicine for elderly patients with cardiovascular diseases[J]. J Geriatr Cardiol, 2013,10(4):305-309
[8] Wang Y, Li C, Liu Z, Shi T, Wang Q, Li D, Wu Y, Han J, Guo S, Tang B, Wang W . Danqi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4[J]. BMC Complement Altern Med, 2014,14:67
doi: 10.1186/1472-6882-14-67
[9] Liu YF, Li N, Jia ZH, Lu F, Pu JL . Chinese medicine Shensongyangxin is effective for patients with bradycardia: results of a randomized, double-blind, placebo-controlled multicenter trial[J].Evid Based Complement Alternat Med, 2014(2014):605714
[10] Chen Y, Fu DY, Chen Y, He YM, Fu XD, Xu YQ, Liu Y, Feng XT, Zhang T, Wang WJ . Effects of Chinese herbal medicine Yiqi Huaju Formula on hypertensive patients with metabolic syndrome: a randomized, placebo-controlled trial[J]. J Integr Med, 2013,11(3):184-194
doi: 10.3736/jintegrmed2013031
[11] Chiu HE, Hong YC, Chang KC, Shih CC, Hung JW, Liu CW, Tan TY, Huang CC . Favorable circulatory system outcomes as adjuvant traditional Chinese medicine(TCM) treatment for cerebrovascular diseases in Taiwan[J]. PLoS One, 2014,9(1):e86351
doi: 10.1371/journal.pone.0086351
[12] Li J, Yu X, Li S, Wang H, Bai Y, Wang M, Sun Z, Zhang W, Zhou Z, Jia X, Zhou Q . Randomized controlled multicenter clinical trial for integrated treatment of community-acquired pneumonia based on traditional Chinese medicine syndrome differentiation[J]. J Tradit Chin Med, 2012,32(4):554-560
doi: 10.1016/S0254-6272(13)60070-9
[13] Xu S, Tian BP, Zhang LH, Hua W, Xia LX, Chen ZH, Li W, Shen HH . Prevention of allergic airway hyperresponsiveness and remodeling in mice by Astragaliradix antiasthmatic decoction[J]. BMC Complement Altern Med, 2013,13:369
doi: 10.1186/1472-6882-13-369
[14] Srivastava K, Sampson HA, Emala CW Sr, Li XM . The anti-asthma herbal medicine ASHMI acutely inhibits airway smooth muscle contraction via prostaglandin E2 activation of EP2/EP4 receptors[J]. Am J Physiol Lung Cell Mol Physiol, 2013,305(12):1002-1010
doi: 10.1152/ajplung.00423.2012
[15] Hu LJ, Hu XM, Yang M, Xie HM, Xiang YH . Clinical effects of the method for warming the middle-jiao and strengthening the spleen on gastric mucosa repair in chronic gastritis patients[J]. J Tradit Chin Med, 2008,28(3):189-192
doi: 10.1016/S0254-6272(08)60044-8
[16] Wan MH, Li J, Huang W, Mukherjee R, Gong HL, Xia Q, Zhu L, Cheng GL, Tang WF . Modified Da-Cheng-Qi Decoction reduces intra-abdominal hypertension in severe acute pancreatitis: a pilot study[J]. Chin Med J (Engl), 2012,125(11):1941-1944
[17] Wang YJ, He LQ, Sun W, Lu Y, Wang XQ, Zhang PQ, Wei LB, Cao SL, Yang NZ, Ma HZ, Gao J, Li P, Tao XJ, Yuan FH, Li J, Yao C, Liu X . Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: a multicenter double-blinded randomized controlled trial[J]. J Ethnopharmacol, 2012,139(3):757-764
doi: 10.1016/j.jep.2011.12.009
[18] Chen YP, Deng YY, Ni ZH, Chen N, Chen XM, Shi W, Zhan YL, Yuan FH, Deng W, Zhong YF . Efficacy and safety of traditional Chinese medicine(Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial[J]. Am J Kidney Dis, 2013,62(6):1068-1076
doi: 10.1053/j.ajkd.2013.05.005
[19] Chen YZ, Gong ZX, Chen XM, Tang L, Zhao XZ, Yuan Q, Cai GY . Tripterygium wilfordii Hook F(a traditional Chinese medicine) for primary nephrotic syndrome[J].Cochrane Database Syst Rev, 2013(11):8
Chen YZ, Gong ZX, Chen XM, Tang L, Zhao XZ, Yuan Q, Cai GY . Tripterygium wilfordii Hook F(a traditional Chinese medicine) for primary nephrotic syndrome[J]. Cochrane Database Syst Rev, 2013,11:8
[20] Pang BZ, Pang QQ, Pang HQ, Song GH . Clinical effect of Jiutengzhuyu tablets on promoting blood circulation in women with oviducal obstruction[J]. J Tradit Chin Med, 2012,32(4):549-553
doi: 10.1016/S0254-6272(13)60069-2
[21] Liu SX, Jiang L, Liu YG, He YQ, Liang X, Kong WW, Chen J . Study on the efficacy and safety of Xueyou Mixture in treating hemophilia[J]. Chin J Integr Med, 2007,13(2):141-144
doi: 10.1007/s11655-007-0141-6
[22] Rufus P, Mohamed N, Shuid AN . Beneficial effects of traditional Chinese medicine on the treatment of osteoporosis on ovariectomised rat models[J]. Curr Drug Targets, 2013,14(14):1689-1693
doi: 10.2174/1389450114666131220160357
[23] Zheng ZX, Wang J, Hou JS, Ma L, Jiang CB . A traditional Chinese medicine therapy warming meridians to nourish blood in treating chronic pain due to soft tissue injury of the neck and shoulder: a randomized controlled trial[J]. J Chin Integr Med, 2011,9(2):153-157
doi: 10.3736/jcim201102
[24] Okada K, Ishimoto S, Fujimaki Y, Yamasoba T . Trial of Chinese medicine Wu-Ling-San for acute low-tone hearing loss[J]. ORL J Otorhinolaryngol Relat Spec, 2012,74(3):158-163
doi: 10.1159/000337819
[25] Guo H, Liu MP . Mechanism of traditional Chinese medicine in the treatment of allergic rhinitis[J]. Chin Med J (Engl), 2013,26(4):756-760
[26] Lin YH, Chen YC, Hu S, Chen HY, Chen JL, Yang SH . Identifying core herbal treatments for urticaria using Taiwan’s nationwide prescription database[J]. J Ethnopharmacol, 2013,48(2):556-562
[27] Shinno H, Inami Y, Inagaki T, Nakamura Y, Horiguchi J . Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2008,32(3):881-885
doi: 10.1016/j.pnpbp.2007.12.027
[28] Zhai XF, Chen Z, Li B, Shen F, Fan J, Zhou WP, Yang YK, Xu J, Qin X, Li LQ, Ling CQ . Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial[J]. J Integr Med, 2013,11(2):90-100
doi: 10.3736/jintegrmed2013021
[29] Tian HQ, Li HL, Wang B, Liang GW, Huang XQ, Huang ZQ, Lang JM, Zhang YP, Chen XZ, Chen YS . Treatment of middle/late stage primary hepatic carcinoma by Chinese medicine comprehensive therapy: a prospective randomized controlled study[J]. Chin J Integr Med, 2010,16(2):102-108
doi: 10.1007/s11655-010-0102-3
[30] Ren H, Cheng L . Clinical observation on the treatment of middle-late stage liver carcinoma by combined therapy of hepato-arterial chemo-embolising and Chinese drugs for strengthening pi and regulating qi[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2004,24(9):838-840
[31] Xu LM, Hu YY . Studies on treatment of fatty liver with traditional Chinese medicine[J]. J Chin Integr Med, 2003,1(2):138-141
doi: 10.3736/jcim
[32] Ge XQ . Experience of treatment for posthepatitic cirrhosis based on TCM syndrome differentiation[J]. Zhongguo Shi Yong Yi Yao, 2008,3(26):160-161
[33] Mi YQ, Cao WK, Xu L, Zhen SW, Pan ZH, Ping L, Zhang H, Dong HJ, Shi G . Clinical study on effect of Jiangan Jiangzhi Pill in treating nonalcoholic fatty liver diseases[J]. Liaoning Zhong Yi Za Zhi, 2010,37(1):97-100
[34] Niu LX . Effects of Baogan Lishui decoction on patients with ascites due to cirrhosis: a report of 84 cases[J]. Guang Ming Zhong Yi, 2010,25(5):808-809
[35] Jiang CY, Wang BE, Chen D, Wang JC . Protective effect of compound Tongfu Granule on intestinal barrier in patients with cirrhosis of decompensation stage[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2008,28(9):784-787
[36] Shi ZL, Chen ZY, Yan MX, He BH, Hong Y . Effects of method of regulating qi to dissipate blood stasis and phlegm with Chinese herbs on expression of SREBP-1c/FAS in rats liver tissue with non-alcoholic steatohepatitis[J]. Zhonghua Zhong Yi Yao Xue Kan, 2013,31(5):1062-1065
[37] Hu XY, Zhang Y, Chen S, Fan XJ . A prospective cohort study on the influence of high doses of herbs for clearing heat and resolving stasis on survival rates in patients with hepatitis B-related acute-on-chronic liver failure[J]. J Chin Integr Med, 2012,10(2):176-185
doi: 10.3736/jcim201202
[38] Wang XJ, Shen Y, Yang L, Liu L, Li B, Zhang LY, Zhou GQ, Yang YY, Sun FX . Clinical observation of clearing heat and removing dampness, cooling blood and detoxicating therapy for acute on chronic liver failure in hepatitis B[J]. Beijing Zhong Yi Yao, 2013,32(3):204-207
[39] Zhang L, Wang G, Hou W, Li P, Dulin A, Bonkovsky HL . Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review[J]. Hepatology, 2010,51(2):690-698
doi: 10.1002/hep.23384
[40] Tsochatzis EA, Bosch J, Burroughs AK . Liver cirrhosis[J]. Lancet, 2014,383(9930):1749-1761
doi: 10.1016/S0140-6736(14)60121-5
[41] Brunner H. Procollagen III levels in serum: do they provide additional information in liver disease? In: Brunner H, Thalar H. Hepatology: a festschrift for Hans Popper.Falk Symposium[M]. New York: Raven Press, 1984: 251
[42] Friedman SL, Bansal MB . Reversal of hepatic fibrosis — fact or fantasy?[J]. Hepatology, 2006,43(2 Suppl 1):S82-S88
doi: 10.1002/(ISSN)1527-3350
[43] Liu P, Liu C, Chen GC, Hu YY, Xu LM, Lü P, Yang JL, Yan RM, Ji Q, Chu F . Effect of Fuzheng Huayu 319 Recipe on serological parameters of fibrosis in treating chronic hepatitis B[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 1996,16(10):588-592
[44] Liu P, Hu YY, Liu C, Xu LM, Liu CH, Sun KW, Hu DC, Yin YK, Zhou XQ, Wan MB, Cai X, Zhang ZQ, Ye J, Tang BZ, He J . Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B[J]. J Chin Integr Med, 2003,1(2):89-98, 102
doi: 10.3736/jcim
[45] Zhu JL, Huang YY, Liu P, Liu C, Xu LM, Hu YY . Effect of Ganping Capsule on posthepatitic cirrhosis in adjusting abnormal immune function[J]. Zhongguo Zhong Yi Yao Ke Ji, 1994,1(2):23-25
[46] Huang YK, Zhao CQ, Hu YY, Xue HM, Liu C, Liu P . Influence of Fuzheng Huayu Capsules on abnormal amino acids spectrum in chronic liver diseases[J]. Zhonghua Gan Zang Bing Za Zhi, 2005,13(3):230-231
[47] Hu YY, Liu C, Liu P, Shen SF, Xu LM, Zhu JL, Xue HM . Effect of Fuzhenhuayu recipe in adjusting endocrine disorders in cirrhotic patient[J]. Zhongguo Yi Yao Xue Bao, 1992,7(5):27-29
[48] She WM, Hu DC, Zhou CH, Gu WG, Wang JY . Clinical research of Ganping Capsule against liver fibrosis in patients with chronic hepatitis B[J]. Gan Zang, 2002,7(4):254-255
[49] Liu P, Hu YY, Liu C, Xu LM, Cheng HL, Hu DC, Yin YK, Zhou XQ, Wan MB, Cai X, Zhang Zhang ZQ, Ye J, Zhou RX, He J, Tang BZ . Multicenter clinical study on Fuzhenghuayu Capsule against liver fibrosis due to chronic hepatitis B[J]. World J Gastroenterol, 2005,11(19):2892-2899
doi: 10.3748/wjg.v11.i19.2892
[50] Mao YM, Zeng MD, Lu LG, Li JQ, Wan MB, Li CZ, Chen CW, Fu QC, Wang JY, She WM, Cai X, Ye J, Zhou XQ, Wang H, Wu SM, Tang MF, Zhu JS, Chen WX, Zhang HQ . Capsule oxymatrine in the treatment of liver fibrosis in patients with chronic virus hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study(II)[J]. Gan Zang, 2002,7(4):222-225
[51] Ji G, Wang YQ, Cao CL . Clinical study on treatment of alcoholic liver disease by Qinggan Huoxue Recipe[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2004,24(1):13-16
[52] Li ZJ, Zhang XE, Su GQ. Peng YQ. Results set of traditional Chinese medicine basic theory research in 973 Program(2005-2006)[M]. Beijing: China Press of Traditional Chinese Medicine, 2011: 179
[53] Gu J, Zhang Q, Xue D, Cai H, Xu L . A randomized controlled study of Fuzheng Huayu Capsule for prevention of esophageal variceal bleeding in patients with liver cirrhosis[J]. Evid Based Complement Alternat Med, 2013,2013:534960
[54] Yu YQ, Zhou Q, Feng DY . Meta-analysis on Fuzhenghuayu Capsule combined with nucleoside antiviral drug for chronic hepatitis B[J]. Ju Jie Shou Shu Xue Za Zhi, 2012,21(1):24-28
[55] Dong MH, Wang J, Zhang HQ, Su YH . Clinical frequently used Chinese crude drugs with hepatoprotective effect[J]. Zhong Yi Yao Dao Bao, 2010,16(4):108-110
[56] Huang GY, Ni RZ . Research progress on mechanism of clinical hepatoprotective drugs[J]. Lin Chuang Gan Dan Bing Za Zhi, 2005,21(3):187-189
[57] Liu C, Hu Y, Xu L, Liu C, Liu P . Effect of Fuzheng Huayu Formula and its actions against liver fibrosis[J]. Chin Med, 2009,4:12
doi: 10.1186/1749-8546-4-12
[58] Wu BR, Zheng YL, Sang XL, Jin M, Wang WZ, Zhang QS, Zhao SX, Kong L . Role of the IGF-1/PI3K pathway and the molecular mechanism of Fuzhenghuayu therapy in a spontaneous recovery rat model of liver fibrosis[J]. Zhonghua Gan Zang Bing Za Zhi, 2013,21(9):674-678
[59] Liu C, Liu P, Liu CH, Zhu XQ, Ji G . Effects of Fuzhenghuayu decoction on collagen synjournal of cultured hepatic stellate cells, hepatocytes and fibroblasts in rats[J]. World J Gastroenterol, 1998,4(6):548-549
doi: 10.3748/wjg.v4.i6.548
[60] Cheung KF, Ye DW, Yang ZF, Lu L, Liu CH, Wang XL, Poon RT, Tong Y, Liu P, Chen YC, Lau GK . Therapeutic efficacy of Traditional Chinese Medicine 319 Recipe on hepatic fibrosis induced by carbon tetrachloride in rats[J]. J Ethnopharmacol, 2009,124(1):142-150
doi: 10.1016/j.jep.2009.03.005
[61] Zhao CQ, Wu YQ, Xu LM . Curative effects of Fuzheng Huayu Capsules on hepatic fibrosis and the functional mechanisms: a review[J]. J Chin Integr Med, 2006,4(5):467-472
doi: 10.3736/jcim
[62] Wang WZ, Meng MH, Kong L, Zhang QS, Zhao SX, Nan YM . Role of Jak/Stat pathway in CCl4-induced rat liver fibrosis model and molecular action mechanism of Fuzheng Huayu Recipe in treatment of liver fibrosis[J]. Lin Chuang Gan Dan Bing Za Zhi, 2014,30(4):344-348
[63] Lv Z, Xu L . Salvianolic acid B inhibits ERK and p38 MAPK signaling in TGF-β1-stimulated human hepatic stellate cell line(LX-2) via distinct pathways[J]. Evid Based Complement Alternat Med, 2012,2012:960128
[64] Xu H, Zhou Y, Lu C, Ping J, Xu LM . Salvianolic acid B lowers portal pressure in cirrhotic rats and attenuates contraction of rat hepatic stellate cells by inhibiting RhoA signaling pathway[J]. Lab Invest, 2012,92(12):1738-1748
doi: 10.1038/labinvest.2012.113
[65] Li S, Wang L, Yan XC, Wang QL, Tao YY, Li JX, Peng Y, Liu P, Liu CH . Salvianolic acid B attenuates rat hepatic fibrosis via downregulating angiotensin II signaling[J]. Evid Based Complement Alternat Med, 2012,2012:160726
[66] Herath CB, Grace JA, Angus PW . Therapeutic potential of targeting the renin angiotensin system in portal hypertension[J]. World J Gastrointest Pathophysiol, 2013,4(1):1-11
doi: 10.4291/wjgp.v4.i1.1
[67] Xu LM, Gu J, Lu X, Zhou Y, Tian T, Zhang J, Xu H. Traditional Chinese medicine can improve liver microcirculation and reduce portal hypertension in liver cirrhosis. In: Garbuzenko DV. Portal hypertension: causes and complications. InTech. 2012: 98-120. (2012-03-14) [2013-11-14]. .
[68] Tao YY, Wang QL, Shen L, Fu WW, Liu CH . Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor β-1 signal transduction pathway in vivo and in vitro[J]. Exp Biol Med (Maywood), 2013,238(11):1284-1296
doi: 10.1177/1535370213498979
[69] Lü Z, Song Y, Xue D, Zhang W, Cheng Y, Xu L . Effect of salvianolic-acid B on inhibiting MAPK signaling induced by transforming growth factor-β1 in activated rat hepatic stellate cells[J]. J Ethnopharmacol, 2010,132(2):384-392
doi: 10.1016/j.jep.2010.05.026
[70] Lin QX, Xu LM . Facing the hepatotoxicity of Chinese herbal medicine[J]. Ya Tai Chuan Tong Yi Yao, 2008,4(6):88-89
[71] Lin QX, Xu LM . Observation of treatment effect and hepatic toxicity of Gardenia in mouse with acute liver injury[J]. Liaoning Zhong Yi Yao Da Xue Xue Bao, 2010,12(6):65-67
[72] Fang HM, Zhu YY . Effective components, toxic effects and research advances of Radix Polygoni Multiflori[J]. Guo Ji Yao Xue Yan Jiu Za Zhi, 2010,37(4):283-286
[73] Fan Y . Present situation of modernization on compound prescriptions[J]. Zhongguo Shi Yan Fang Ji Xue Za Zhi, 2007,13(6):63-65
[74] Miao JX, Miao MS . Research status, problems and thinking of multi-component of Chinese medicine[J]. Zhong Yi Xue Bao, 2012,27(9):1116-1119
[75] Chen XP, Pei LX, Wang YT . Discussion on research and development models in innovative Chinese material medica[J]. Zhong Cao Yao, 2011,42(7):1255-1260
[1] Brody Slostad, Tejinder Khalsa, Kathleen Young, Hildalicia Guerra, Anjali Bhagra. A case-based approach to integrative medicine for cardiovascular disease prevention. Journal of Integrative Medicine, 2020, 18(2): 159-162.
[2] Ameena Yasmeen, Ghulamuddin Sofi, Kaleemullah Khan. Aamar-e-Advia (shelf-lives) of drugs in Unani system of medicine: A conceptual review. Journal of Integrative Medicine, 2020, 18(2): 114-124.
[3] Louisa Sylvia, Emerson West, Allyson M. Blackburn, Carina Gupta, Eric Bui, Tara Mahoney, Geraldine Duncan, Edward C. Wright, Simon Lejeune, Thomas J. Spencer. Acceptability of an adjunct equine-assisted activities and therapies program for veterans with posttraumatic stress disorder and/or traumatic brain injury. Journal of Integrative Medicine, 2020, 18(2): 169-173.
[4] Deng-hai Zhang, Kun-lun Wu, Xue Zhang, Sheng-qiong Deng, Bin Peng. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. Journal of Integrative Medicine, 2020, 18(2): 152-158.
[5] Chang-quan Ling. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2). Journal of Integrative Medicine, 2020, 18(2): 87-88.
[6] Sherman Gu, Arthur Yin Fan. Controversial conclusions from two randomized controlled trials for acupuncture's effects on polycystic ovary syndrome or in vitro fertilization support. Journal of Integrative Medicine, 2020, 18(2): 89-91.
[7] Xue-qing Yu, Shu-guang Yang, Yang Xie, Jian-sheng Li. Traditional Chinese medicine in the treatment of idiopathic pulmonary fibrosis based on syndrome differentiation: Study protocol of exploratory trial. Journal of Integrative Medicine, 2020, 18(2): 163-168.
[8] Mohadeseh Ostovar, Abolfazl Akbari, Mohammad Hossein Anbardar, Aida Iraji, Mohsen Salmanpour, Salar Hafez Ghoran, Mojtaba Heydari, Mesbah Shams. Effects of Citrullus colocynthis L. in a rat model of diabetic neuropathy. Journal of Integrative Medicine, 2020, 18(1): 59-67.
[9] Preecha Nootim, Nattiya Kapol, Waranee Bunchuailua, Panoopat Poompruek, Parankul Tungsukruthai . Current state of cancer patient care incorporating Thai traditional medicine in Thailand: A qualitative study. Journal of Integrative Medicine, 2020, 18(1): 41-45.
[10] Sajjad Sadeghi, Farzaneh Ghaffari, Ghazaleh Heydarirad, Mehdi Alizadeh. Galen’s place in Avicenna’s The Canon of Medicine : Respect, confirmation and criticism. Journal of Integrative Medicine, 2020, 18(1): 21-25.
[11] Maryam Naeimia, Narjes Gorjib, Zahra Memarianib, Reihaneh Moeinib, Mohammad Kamalinejadc, Fatemeh Kolangid. Gastroprotective herbs for headache management in Persian medicine: A comprehensive review. Journal of Integrative Medicine, 2020, 18(1): 1-13.
[12] Md. Anzar Alam, Mohd Aleemuddin Quamri, Ghulamuddin Sofi, Barkati Md.Tarique. Understanding hypothyroidism in Unani medicine. Journal of Integrative Medicine, 2019, 17(6): 387-391.
[13] Naghmeh Yazdi, Alireza Salehi, Mina Vojoud, Mohammad Hossein Sharifi, Ayda Hoseinkhani. Use of complementary and alternative medicine in pregnant women: a cross-sectional survey in the south of Iran. Journal of Integrative Medicine, 2019, 17(6): 392-395.
[14] Wen Qiang Lee, Jeremy Teoh, Pei Zheng Kenneth Lee, Zhi Xiong Gerard Low, Xueling Sim, Foong Fong Mary Chong, Norbert Ludwig Wagner. Factors influencing communication of traditional Chinese medicine use between patients and doctors: a multisite cross-sectional study. Journal of Integrative Medicine, 2019, 17(6): 396-403.
[15] Zienab Mahmoudpour, Javad Shokri, Mohammad Kamalinejad, Neda Meftah, Soraya Khafri, Seyyed Ali Mozaffarpur, Hoda Shirafkan. The efficacy of a Persian herbal formulation on functional bloating: A double-blind randomized controlled trial. Journal of Integrative Medicine, 2019, 17(5): 344-350.
Full text



[1] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[2] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[3] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[4] Xi Lin, Jian-ping Liu. Tai chi for treating rheumatoid arthritis. Journal of Chinese Integrative Medicine, 2008, 6(1): 82
[5] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Yan-bo Zhu , Qi Wang, Cheng-yu Wu, Guo-ming Pang, Jian-xiong Zhao, Shi-lin Shen, Zhong-yuan Xia , Xue Yan . Logistic regression analysis on relationships between traditional Chinese medicine constitutional types and overweight or obesity. Journal of Chinese Integrative Medicine, 2010, 8(11): 1023-1035
[8] Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[9] Wei Xu, Meng Shi, Jian-gang Liu, Cheng-long Wang . Collagen protein expressions in ischemic myocardium of rats with acute myocardial infarction and effects of qi-tonifying, yin-tonifying and blood-activating herbs and detoxifying and blood-activating herbs. Journal of Chinese Integrative Medicine, 2010, 8(11): 1041-1047
[10] Ya-bing Zhou, Jian-er Yu, Jie Wu, Li Bai, Li-li Huo, Xin-guang Zhang, Li-qing Li . Effects of Chinese herbal medicine Bushen Gubiao Recipe on toll-like receptor 4 and CD4 +CD25 +foxp3 +regulatory T cells in mice with recurrent respiratory tract infections. Journal of Chinese Integrative Medicine, 2010, 8(11): 1053-1059